Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp).
Kalra S, Atkin S, Cervera A, Das AK, Demir O, Demir T, Fariduddin M, Vo KT, Ku BJ, Kumar A, Latif ZA, Malek R, Matawaran BJ, Mehta R, Tran NQ, Panelo A, Ruder S, Saldana JR, Shaikh KA, Shakya A, Shrestha D, Unnikrishnan AG. Kalra S, et al. Among authors: matawaran bj. Adv Ther. 2018 Jul;35(7):928-936. doi: 10.1007/s12325-018-0712-2. Epub 2018 May 23. Adv Ther. 2018. PMID: 29796928 Review.
Correction to: Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp).
Kalra S, Atkin S, Cervera A, Das AK, Demir O, Demir T, Fariduddin M, Vo KT, Ku BJ, Kumar A, Latif ZA, Malek R, Matawaran BJ, Mehta R, Tran NQ, Panelo A, Ruder S, Saldana JR, Shaikh KA, Shakya A, Shrestha D, Unnikrishnan AG. Kalra S, et al. Among authors: matawaran bj. Adv Ther. 2018 Jul;35(7):937-938. doi: 10.1007/s12325-018-0728-7. Adv Ther. 2018. PMID: 29882121
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
Deerochanawong C, Chan SP, Matawaran BJ, Sheu WH, Chan J, Man NH, Suastika K, Khoo CM, Yoon KH, Luk A, Mithal A, Linong J. Deerochanawong C, et al. Among authors: matawaran bj. Diabetes Obes Metab. 2019 Nov;21(11):2354-2367. doi: 10.1111/dom.13819. Epub 2019 Jul 17. Diabetes Obes Metab. 2019. PMID: 31264765 Free PMC article. Review.
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
Khoo CM, Deerochanawong C, Chan SP, Matawaran B, Sheu WH, Chan J, Mithal A, Luk A, Suastika K, Yoon KH, Ji L, Man NH, Pollock C. Khoo CM, et al. Diabetes Obes Metab. 2021 Feb;23(2):299-317. doi: 10.1111/dom.14251. Epub 2020 Nov 20. Diabetes Obes Metab. 2021. PMID: 33155749 Free PMC article. Review.
Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Tan JWC, Sim D, Ako J, Almahmeed W, Cooper ME, Dalal JJ, Deerochanawong C, Huang DWC, Johar S, Kaul U, Kim SG, Koh N, Kong AP, Krittayaphong R, Kwok B, Matawaran BJ, Nguyen QN, Ong LM, Park JJ, Peng Y, Quek DK, Suastika K, Sukor N, Teo BW, Teoh CK, Zhang J, Reyes EB, Goh SY. Tan JWC, et al. Among authors: matawaran bj. Eur Cardiol. 2021 Apr 19;16:e14. doi: 10.15420/ecr.2020.52. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 33976709 Free PMC article. Review.
12 results